Showing results (1-10 of 376) with videos related to
Sort By:
Pageof 38
Critical Care (London, England)|February 14, 2006
Do statins have a role in preventing or treating sepsis?Victor Novack, Marius Terblanche, Yaniv AlmogHarefuah|December 25, 2013
[Atrial fibrillation in medical intensive care unit patients: characteristics and consequences]Yael Baumfeld, Victor Novack, Yaniv AlmogIntensive Care Medicine|February 12, 2009
The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trialVictor Novack, Miruna Eisinger, Amit Frenkel, et al.European Journal of Internal Medicine|May 17, 2011
Exertional heatstroke: clinical characteristics, diagnostic and therapeutic considerationsLior Zeller, Victor Novack, Leonid Barski, et al.Critical Care (London, England)|September 3, 2005
The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort studyDaniel A King, Shlomi Codish, Victor Novack, et al.The Lancet. Infectious Diseases|March 24, 2006
Statins: panacea for sepsis?Marius Terblanche, Yaniv Almog, Robert S Rosenson, et al.The Lancet. Infectious Diseases|April 24, 2007
Statins and sepsis: multiple modifications at multiple levelsMarius Terblanche, Yaniv Almog, Robert S Rosenson, et al.Critical Care Medicine|January 6, 2007
The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseasesYaniv Almog, Victor Novack, Miruna Eisinger, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 21, 2012
The effect of rosuvastatin on incident pneumonia: results from the JUPITER trialVictor Novack, Jean MacFadyen, Atul Malhotra, et al.Anesthesia and Analgesia|May 24, 2006
Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patientsYaniv Almog, Victor Novack, Rinat Megralishvili, et al.Pageof 38